Literature DB >> 23273602

Traumatic brain injury in aged animals increases lesion size and chronically alters microglial/macrophage classical and alternative activation states.

Alok Kumar1, Bogdan A Stoica, Boris Sabirzhanov, Mark P Burns, Alan I Faden, David J Loane.   

Abstract

Traumatic brain injury (TBI) causes chronic microglial activation that contributes to subsequent neurodegeneration, with clinical outcomes declining as a function of aging. Microglia/macrophages (MG/Mɸ) have multiple phenotypes, including a classically activated, proinflammatory (M1) state that might contribute to neurotoxicity, and an alternatively activated (M2) state that might promote repair. In this study we used gene expression, immunohistochemical, and stereological analyses to show that TBI in aged versus young mice caused larger lesions associated with an M1/M2 balance switch and increased numbers of reactive (bushy and hypertrophic) MG/Mɸ in the cortex, hippocampus, and thalamus. Chitinase3-like 3 (Ym1), an M2 phenotype marker, displayed heterogeneous expression after TBI with amoeboid-like Ym1-positive MG/Mɸ at the contusion site and ramified Ym1-positive MG/Mɸ at distant sites; this distribution was age-related. Aged-injured mice also showed increased MG/Mɸ expression of major histocompatibility complex II and NADPH oxidase, and reduced antioxidant enzyme expression which was associated with lesion size and neurodegeneration. Thus, altered relative M1/M2 activation and an nicotinamide adenine dinucleotide phosphate oxidase (NADPH oxidase)-mediated shift in redox state might contribute to worse outcomes observed in older TBI animals by creating a more proinflammatory M1 MG/Mɸ activation state.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23273602      PMCID: PMC3572914          DOI: 10.1016/j.neurobiolaging.2012.11.013

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  68 in total

1.  NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.

Authors:  Du-Chu Wu; Peter Teismann; Kim Tieu; Miquel Vila; Vernice Jackson-Lewis; Harry Ischiropoulos; Serge Przedborski
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-29       Impact factor: 11.205

2.  Th1/Th2-regulated expression of arginase isoforms in murine macrophages and dendritic cells.

Authors:  M Munder; K Eichmann; J M Morán; F Centeno; G Soler; M Modolell
Journal:  J Immunol       Date:  1999-10-01       Impact factor: 5.422

Review 3.  Role of microglia in neurotrauma.

Authors:  David J Loane; Kimberly R Byrnes
Journal:  Neurotherapeutics       Date:  2010-10       Impact factor: 7.620

4.  Microglial activation and chronic neurodegeneration.

Authors:  Melinda E Lull; Michelle L Block
Journal:  Neurotherapeutics       Date:  2010-10       Impact factor: 7.620

5.  Traumatic brain injury in an aging population.

Authors:  Nino Stocchetti; Rosalia Paternò; Giuseppe Citerio; Luigi Beretta; Angelo Colombo
Journal:  J Neurotrauma       Date:  2012-04-02       Impact factor: 5.269

6.  Lipopolysaccharide-induced interleukin (IL)-4 receptor-α expression and corresponding sensitivity to the M2 promoting effects of IL-4 are impaired in microglia of aged mice.

Authors:  Ashley M Fenn; Christopher J Henry; Yan Huang; Allison Dugan; Jonathan P Godbout
Journal:  Brain Behav Immun       Date:  2011-10-17       Impact factor: 7.217

7.  NADPH oxidase is involved in post-ischemic brain inflammation.

Authors:  Hai Chen; Gab Seok Kim; Nobuya Okami; Purnima Narasimhan; Pak H Chan
Journal:  Neurobiol Dis       Date:  2011-02-15       Impact factor: 5.996

8.  The effects of aging, injury and disease on microglial function: a case for cellular senescence.

Authors:  Kelly R Miller; Wolfgang J Streit
Journal:  Neuron Glia Biol       Date:  2007-08

9.  Inhibition of NADPH oxidase is neuroprotective after ischemia-reperfusion.

Authors:  Hai Chen; Yun Seon Song; Pak H Chan
Journal:  J Cereb Blood Flow Metab       Date:  2009-05-06       Impact factor: 6.200

Review 10.  Heterogeneity of microglial activation in the innate immune response in the brain.

Authors:  Carol A Colton
Journal:  J Neuroimmune Pharmacol       Date:  2009-08-05       Impact factor: 4.147

View more
  129 in total

1.  Sequential activation of microglia and astrocyte cytokine expression precedes increased Iba-1 or GFAP immunoreactivity following systemic immune challenge.

Authors:  Diana M Norden; Paige J Trojanowski; Emmanuel Villanueva; Elisa Navarro; Jonathan P Godbout
Journal:  Glia       Date:  2015-10-15       Impact factor: 7.452

2.  Osteopontin expression in acute immune response mediates hippocampal synaptogenesis and adaptive outcome following cortical brain injury.

Authors:  Julie L Chan; Thomas M Reeves; Linda L Phillips
Journal:  Exp Neurol       Date:  2014-08-21       Impact factor: 5.330

Review 3.  Progressive inflammation-mediated neurodegeneration after traumatic brain or spinal cord injury.

Authors:  Alan I Faden; Junfang Wu; Bogdan A Stoica; David J Loane
Journal:  Br J Pharmacol       Date:  2015-06-12       Impact factor: 8.739

Review 4.  NADPH oxidase- and mitochondria-derived reactive oxygen species in proinflammatory microglial activation: a bipartisan affair?

Authors:  Evan A Bordt; Brian M Polster
Journal:  Free Radic Biol Med       Date:  2014-08-01       Impact factor: 7.376

Review 5.  Microglia and macrophage metabolism in CNS injury and disease: The role of immunometabolism in neurodegeneration and neurotrauma.

Authors:  Nicholas A Devanney; Andrew N Stewart; John C Gensel
Journal:  Exp Neurol       Date:  2020-04-11       Impact factor: 5.330

6.  Reducing age-dependent monocyte-derived macrophage activation contributes to the therapeutic efficacy of NADPH oxidase inhibition in spinal cord injury.

Authors:  Bei Zhang; William M Bailey; Anna Leigh McVicar; Andrew N Stewart; Amy K Veldhorst; John C Gensel
Journal:  Brain Behav Immun       Date:  2018-11-16       Impact factor: 7.217

7.  CCR2 deficiency impairs macrophage infiltration and improves cognitive function after traumatic brain injury.

Authors:  Christine L Hsieh; Erene C Niemi; Sarah H Wang; Chih Cheng Lee; Deborah Bingham; Jiasheng Zhang; Myrna L Cozen; Israel Charo; Eric J Huang; Jialing Liu; Mary C Nakamura
Journal:  J Neurotrauma       Date:  2014-07-21       Impact factor: 5.269

8.  Age-related differences in interferon regulatory factor-4 and -5 signaling in ischemic brains of mice.

Authors:  Shou-Cai Zhao; Chun Wang; Heng Xu; Wen-Qian Wu; Zhao-Hu Chu; Ling-Song Ma; Ying-Dong Zhang; Fudong Liu
Journal:  Acta Pharmacol Sin       Date:  2017-09-14       Impact factor: 6.150

Review 9.  Inflammation, Glutamate, and Glia: A Trio of Trouble in Mood Disorders.

Authors:  Ebrahim Haroon; Andrew H Miller; Gerard Sanacora
Journal:  Neuropsychopharmacology       Date:  2016-09-15       Impact factor: 7.853

10.  Novel mGluR5 positive allosteric modulator improves functional recovery, attenuates neurodegeneration, and alters microglial polarization after experimental traumatic brain injury.

Authors:  David J Loane; Bogdan A Stoica; Flaubert Tchantchou; Alok Kumar; James P Barrett; Titilola Akintola; Fengtian Xue; P Jeffrey Conn; Alan I Faden
Journal:  Neurotherapeutics       Date:  2014-10       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.